CRO质谱服务的全球市场

预计到 2030 年，全球 CRO 质谱服务市场规模将达到 22 亿美元

全球CRO质谱服务市场规模预计在2024年达到9.3亿美元，预计在分析期内（2024-2030年）将以15.7%的复合年增长率增长，到2030年将达到22亿美元。蛋白质体学服务是本报告分析的细分市场之一，预计在分析期结束时，其复合年增长率将达到16.2%，达到14亿美元。代谢体学服务细分市场在分析期间的复合年增长率预计为14.0%。

美国市场规模估计为 2.534 亿美元，中国市场预计复合年增长率为 20.9%

预计2024年美国CRO质谱服务市场规模将达2.534亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到4.866亿美元，在2024-2030年的分析期间内，复合年增长率为20.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为11.5%和14.1%。在欧洲，预计德国市场的复合年增长率约为12.5%。

全球CRO质谱服务市场－主要趋势与驱动因素摘要

CRO质谱服务为何需求旺盛？探索先进分析测试的需求

由于药物开发日益复杂、监管要求日益严格，以及製药和生物技术行业对高精度分析测试的需求日益增长，委外研发机构(CRO) 提供的全球质谱服务市场正在迅速扩张。质谱分析是鑑定化合物、检测杂质以及高灵敏度和准确度表征生物分子的关键技术。随着生物製药公司专注于提高药物安全性和疗效，将分析测试外包给 CRO 已成为一种经济高效的解决方案。个人化医疗、生物相似药和复杂生技药品的兴起进一步推动了对专业质谱服务的需求。

CRO市场领先的质谱服务有哪些？主要细分领域

CRO质谱服务市场涵盖各种专门的分析技术，以满足各种研究和监管需求。液相层析法质谱法 (LC-MS) 广泛应用于药物研发、药物动力学和代谢体学研究。气相层析法质谱法 (GC-MS) 仍然是挥发性化合物分析以及环境和法医学检测的重要技术。高解析度质谱法 (HRMS) 和串联式质谱质谱法 (MS/MS) 对于蛋白质体学和生物标记的发现至关重要。此外，质谱成像 (MSI) 在生物医学研究中越来越受欢迎，可用于组织分析和疾病分析。自动化与人工智慧驱动的数据分析的整合进一步增强了质谱分析能力，提高了通量和准确性。

科技将如何改变CRO质谱服务：人工智慧、自动化和即时分析的作用

由于采用人工智慧驱动的数据处理、自动化和即时分子分析技术的进步，CRO质谱产业正在蓬勃发展。人工智慧驱动的质谱软体改进了频谱解析，缩短了识别复杂化合物所需的时间。环境电离质谱等即时质谱技术的发展，使得临床和製药应用的样本分析速度更快。此外，样品製备和高通量筛检的自动化提高了CRO实验室的效率和扩充性。云端基础的资料管理解决方案还促进了远端协作和法规遵循，使全球研究团队能够无缝存取分析结果。

推动CRO质谱服务市场成长的因素有哪些？关键市场影响因素说明

CRO质谱服务市场的成长得益于医药研发投入的增加、监管审查的加强以及对高精度生物分析测试的需求。生技药品和基因治疗研究的扩展为专门从事基于质谱的生物分子分析的CRO创造了新的商机。此外，食品安全、环境监测和法医学对品管的需求日益增长，也拓宽了市场的应用范围。向合约研究外包的转变使製药公司能够简化其药物开发流程，从而进一步增强CRO质谱部门的实力。持续的技术进步和日益增长的分析需求预计将在未来几年推动市场持续成长。

部分

服务类型（蛋白质体学服务、代谢体学服务、其他服务）；最终用户（製药/生物製药公司、医疗设备公司、其他最终用户）

受访公司范例

• 360biolabs
• ABC Laboratories
• Accurant Biotech
• ACM Global Laboratories
• Active Biomarkers
• Alderley Analytical
• Alliance Pharma
• Allumiqs
• Altasciences
• Analytik Jena
• BioAgilytix
• Charles River Laboratories
• CovalX
• Creative Proteomics
• Labcorp Drug Development
• MS Bioworks
• Novatia
• Omics Solutions
• PPD Laboratories
• Waters Corporation

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global CRO Mass Spectroscopy Services Market to Reach US$2.2 Billion by 2030

The global market for CRO Mass Spectroscopy Services estimated at US$930.0 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Proteomics Services, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Metabolomics Services segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$253.4 Million While China is Forecast to Grow at 20.9% CAGR

The CRO Mass Spectroscopy Services market in the U.S. is estimated at US$253.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$486.6 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global CRO Mass Spectroscopy Services Market - Key Trends & Drivers Summarized

Why Are CRO Mass Spectroscopy Services in High Demand? Exploring the Need for Advanced Analytical Testing

The global contract research organization (CRO) mass spectroscopy services market is expanding rapidly due to the increasing complexity of drug development, stringent regulatory requirements, and the growing demand for high-precision analytical testing in pharmaceutical and biotechnology industries. Mass spectrometry is a crucial technique for identifying chemical compounds, detecting impurities, and characterizing biomolecules with high sensitivity and accuracy. As biopharmaceutical companies focus on improving drug safety and efficacy, outsourcing analytical testing to CROs has become a cost-effective solution. The rise of personalized medicine, biosimilars, and complex biologics has further driven the demand for specialized mass spectrometry services.

Which Mass Spectroscopy Services Are Leading the CRO Market? A Breakdown of Key Segments

The CRO mass spectroscopy services market includes various specialized analytical techniques tailored for different research and regulatory needs. Liquid chromatography-mass spectrometry (LC-MS) is widely used for drug discovery, pharmacokinetics, and metabolomics studies. Gas chromatography-mass spectrometry (GC-MS) remains a key technique for environmental and forensic testing, as well as volatile compound analysis. High-resolution mass spectrometry (HRMS) and tandem mass spectrometry (MS/MS) are essential for proteomics and biomarker discovery. Additionally, mass spectrometry imaging (MSI) is gaining traction in biomedical research for tissue analysis and disease profiling. The integration of automation and AI-driven data analysis has further enhanced mass spectrometry capabilities, improving throughput and precision.

How Is Technology Transforming CRO Mass Spectrometry Services? The Role of AI, Automation & Real-Time Analysis

The CRO mass spectrometry industry is evolving with technological advancements in AI-driven data processing, automation, and real-time molecular analysis. AI-powered mass spectrometry software has improved spectral interpretation, reducing the time required for complex compound identification. The development of real-time mass spectrometry techniques, such as ambient ionization mass spectrometry, has enabled faster sample analysis in clinical and pharmaceutical applications. Additionally, automation in sample preparation and high-throughput screening has enhanced efficiency and scalability in CRO laboratories. Cloud-based data management solutions have also facilitated remote collaboration and regulatory compliance, ensuring seamless access to analytical results across global research teams.

What’s Driving the Growth of the CRO Mass Spectrometry Services Market? Key Market Influencers Explained

The growth in the CRO mass spectrometry services market is driven by increasing pharmaceutical R&D investments, rising regulatory scrutiny, and the demand for high-precision bioanalytical testing. The expansion of biologics and gene therapy research has created new opportunities for CROs specializing in mass spectrometry-based biomolecular analysis. Additionally, the growing need for quality control in food safety, environmental monitoring, and forensic science has broadened market applications. The shift toward contract-based research outsourcing has allowed pharmaceutical companies to streamline their drug development processes, further strengthening the CRO mass spectrometry sector. With continuous technological advancements and increasing analytical requirements, the market is expected to experience sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the CRO Mass Spectroscopy Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Proteomics Services, Metabolomics Services, Other Services); End-Use (Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• 360biolabs
• ABC Laboratories
• Accurant Biotech
• ACM Global Laboratories
• Active Biomarkers
• Alderley Analytical
• Alliance Pharma
• Allumiqs
• Altasciences
• Analytik Jena
• BioAgilytix
• Charles River Laboratories
• CovalX
• Creative Proteomics
• Labcorp Drug Development
• MS Bioworks
• Novatia
• Omics Solutions
• PPD Laboratories
• Waters Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • CRO Mass Spectroscopy Services - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for High-Precision Analytical Services Drives Growth in CRO Mass Spectrometry Services
  • Surge in Biopharmaceutical and Biotechnology Research Expands Addressable Market for Mass Spectrometry in Drug Development
  • Rising Complexity of Drug Discovery and Development Processes Strengthens Business Case for Advanced Mass Spectrometry Solutions
  • Technological Advancements in Mass Spectrometry Instrumentation Drive Market Innovation and Demand for Outsourced Services
  • Growing Focus on Personalized Medicine and Targeted Therapies Accelerates the Need for Advanced Mass Spectrometry in Clinical Trials
  • Expansion of Proteomics and Metabolomics Research Generates New Opportunities for CRO Mass Spectrometry Services
  • Increasing Investment in R&D by Pharmaceutical Companies Spreads Demand for Mass Spectrometry Services in Drug Discovery
  • The Integration of Mass Spectrometry with Other Analytical Techniques Expands Market Opportunity for Multi-Technique Research Solutions
  • The Rising Popularity of Biomarker Discovery Drives Accelerated Demand for Mass Spectrometry in Clinical and Translational Research
  • Advancements in Quantitative Mass Spectrometry and Data Analysis Strengthen the Business Case for Accurate, Reproducible Results
  • Increasing Demand for High-Throughput and Automation in Research Drives Growth in Mass Spectrometry Service Offerings
  • Regulatory Pressures for Enhanced Safety and Efficacy of Drugs Strengthens the Case for Mass Spectrometry in Compliance Testing
  • Rising Demand for Environmental and Food Safety Testing Expands Market for CRO Mass Spectrometry Services in Non-Pharma Sectors
  • The Growth of Contract Research Organizations (CROs) in Emerging Markets Expands the Global Reach of Mass Spectrometry Services
  • Focus on Reducing Drug Development Costs and Time-to-Market Drives Adoption of CRO Mass Spectrometry Services in Early-Stage Research
  • Increasing Complexity of Biologics and Biosimilars Development Propels Market Demand for Mass Spectrometry in Protein Analysis
  • The Integration of Artificial Intelligence and Machine Learning with Mass Spectrometry Services Generates New Analytical Capabilities
  • The Need for High-Quality and Comprehensive Data in Clinical Trials Propels Demand for Advanced Mass Spectrometry in Regulatory Submissions
  • Heightened Interest in Translational Medicine and Diagnostics Creates Opportunities for Mass Spectrometry in Disease Biomarker Research
  • The Rise in Outsourcing Analytical Services by Pharmaceutical Companies Expands Market for CRO Mass Spectrometry Service Providers
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World CRO Mass Spectroscopy Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for CRO Mass Spectroscopy Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Proteomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Proteomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Proteomics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Metabolomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Metabolomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Metabolomics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Medical device companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Medical device companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Medical device companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: USA 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: Canada 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: Canada 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: Japan 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Japan 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: China 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: China 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for CRO Mass Spectroscopy Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: France 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: France Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: France 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Germany 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Germany 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Italy 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Italy 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: UK 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: UK 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Spain 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Spain 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Russia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Russia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Rest of Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Rest of Europe 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 107: Australia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Australia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 110: Australia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Australia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 113: India Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: India Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: India 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 116: India Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: India Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: India 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: South Korea 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: South Korea 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Argentina 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Argentina 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Brazil 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Brazil 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Mexico 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Mexico 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Rest of Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 173: Iran Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Iran 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 176: Iran Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Iran 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 179: Israel Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Israel 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 182: Israel Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Israel 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Saudi Arabia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Saudi Arabia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 191: UAE Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: UAE 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 194: UAE Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: UAE 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 203: Africa Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Africa 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
  • TABLE 206: Africa Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Africa 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION